Details

Last Funding Type

Series C

Last Funding Money Raised

¥1B

Industries

Biotechnology,Life Science

Founded date

Jan 1, 2017

Number Of Employee

11 - 50

Operating Status

Active

Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as well as financial support. Sinovent uniquely combines its expertise in science, management and finance, to develop and promote advanced treatment methods to solve worldwide healthcare problems. Currently, the company has 12 products in development, primarily in oncology, auto-immune diseases, and infectious diseases.